V
40
4
IVZ
45
3
SPG
40
2
F
60
5
VRTX
66
11
LOW
45
2
NEM
69
-3
LEN
28
2
TXT
76
3
RL
70
5
AMT
47
2
SWKS
43
3
CTSH
42
3
KO
59
4
TRV
52
4
LRCX
68
4
AEP
75
3
WMB
58
3
AES
72
4
DE
78
2
V
40
4
IVZ
45
3
SPG
40
2
F
60
5
VRTX
66
11
LOW
45
2
NEM
69
-3
LEN
28
2
TXT
76
3
RL
70
5
AMT
47
2
SWKS
43
3
CTSH
42
3
KO
59
4
TRV
52
4
LRCX
68
4
AEP
75
3
WMB
58
3
AES
72
4
DE
78
2
Financhill
Back

CVR Partners LP 10K Form

Sell
40

UAN
CVR Partners LP

Last Price:
$100.75
Seasonality Move:
9.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UAN News And Ratings

See the #1 stock for the next 7 days that we like better than UAN

UAN Financial Statistics

Sales & Book Value

Annual Sales: $606M
Cash Flow: $-45.2M
Price / Cash Flow: 10.78
Annual Sales: $25.14
Price / Book: 4.01

Profitability

EPS (TTM): 9.33410
Net Income (TTM): $98.7M
Gross Margin: $163.4M
Return on Equity: 32.99%
Return on Assets: 9.79%

CVR Partners LP Earnings Forecast

Key CVR Partners LP Financial Ratios

  • The Gross Profit Margin over the past 18 years for UAN is 26.96%.
  • The Selling, General & Administrative Expenses for UAN have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 30.76% of Operating Income.
  • The Net Earning history of UAN is 16.28% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

CVR Partners LP Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Chemicals
Sector: Materials
Current Symbol: UAN
CUSIP: 126633
Website: cvrpartners.com

Debt

Debt-to-Equity Ratio: 2.2
Current Ratio: 2.21
Quick Ratio: 1.32

Price-to-Earnings

Trailing P/E Ratio: 10.8
Forward P/E Ratio: 0

UAN Technical Analysis vs Fundamental Analysis

Sell
40
CVR Partners LP (UAN) is a Sell

Is CVR Partners LP a Buy or a Sell?

  • CVR Partners LP stock is rated a Sell
    The current CVR Partners LP [UAN] share price is $100.80. The Score for UAN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.